-
Information-Publications
-
A population antibody response against SARS-CoV-2 with differential neutralization activities towards the Delta and Omicron variantsDetails
-
Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic fieldDetails
-
The Gelation of CAG Repeat Expansion RNAs Suppresses Global Protein TranslationDetails
-
TMUB1 is an endoplasmic reticulum-resident escortase that promotes the p97-mediated extraction of membrane proteins for degradationDetails
-
Local hyperthermia therapy induces browning of white fat and treats obesityDetails
-
A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibilityDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands